XCellAssay
Private Company
Funding information not available
Overview
XCellAssay is a private, early-stage diagnostics company developing a novel bioassay platform for comprehensive chemical contaminant detection in drinking water. Founded in 2010 and based in Berkeley, California, the company leverages engineered cells and robotic detection to identify endocrine disruptors and other industrial chemicals beyond the EPA's standard 90-contaminant list. With recent non-dilutive grant funding and academic partnership support, XCellAssay is validating its technology with state water agencies and positioning itself to address a significant gap in environmental health monitoring.
Technology Platform
Multiplexed bioassay platform using engineered cells (e.g., nuclear receptor assays) and robotic detection to identify chemical contaminants in water based on their biological activity.
Opportunities
Risk Factors
Competitive Landscape
Competition includes large commercial water testing labs (e.g., Eurofins, SGS) using mass spectrometry, which is precise for targeted chemicals but expensive for broad panels. Other startups may be developing similar bioassay or sensor-based approaches. XCellAssay's differentiation is its focus on multiplexed, functional biological response data at a claimed low cost.